It did not have a significantly different therapeutic efficacy from the commercial paste dosage form in the treatment of oral lichen planus. Buffering agents and an antioxidant should be added to ...

Introduction Oral lichen planus (OLP) is an idiopathic chronic mucocutaneous disease with ... Partial resolution will be considered when a decrease, but not a complete remission of atrophic/erosive ...

The results of this preliminary study suggest that this mouthwash was a safe and effective therapy for reducing the signs and symptoms of oral lichen planus. However, the therapeutic effectiveness ...

Currently, there are no FDA-approved pharmacotherapies for Oral Lichen Planus, and LP-310 is the only topical treatment in development for OLP. About the Study The Oral Lichen Planus Clinical ...

(Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing ...